MedPath

Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection

Not Applicable
Completed
Conditions
ARDS
Non Invasive Ventilation
Prone Positioning
Covid19
Hypoxemic Respiratory Failure
High Flow Nasal Cannulla
Interventions
Other: Body position change
Registration Number
NCT04694638
Lead Sponsor
Mayo Clinic
Brief Summary

This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • Patients with confirmed COVID19 infection or suspected COVID19 infection.
  • Patients requiring HFNC or NIPPV
  • Patients who are clinically stable and able to tolerate the changes in position that are routinely conducted as part of the standard of care in the medical ICU.
  • Patient should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.
  • Able to actively participate in Assisted Manual Pronation Therapy per nursing assessment.
Read More
Exclusion Criteria

Contraindication for prone positioning:

  • Intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mmHg
  • Massive hemoptysis requiring an immediate surgical or interventional radiology procedure
  • Tracheal surgery or sternotomy during the previous 15 days
  • Serious facial trauma or facial surgery during the previous 15 days
  • Deep venous thrombosis treated for less than 2 days
  • Cardiac pacemaker inserted in the last 2 days
  • Unstable spine, femur, or pelvic fractures
  • Hemodynamic instability or severe cardiac arrhythmia (chronic AFib is not a contraindication). Mean arterial pressure lower than 60 mm Hg, >1 vasopressor agent or Norepinephrine equivalent dose >0.06 mcg/kg/min
  • Pregnant women
  • Single anterior chest tube with air leaks
  • Burns on more than 20 % of the body surface
  • Delirium or altered mental status increasing fall risk while in prone position.
  • End-of-life decision before inclusion
  • Subject deprived of freedom, minor, subject under a legal protective measure
  • Unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment
  • Lacking capacity to provide informed consent.
  • Individuals with mechanical or vascular disease precluding safe displacement of the head, for example: cervical spinal fusion, limited range of motion, or severe vascular occlusive disease of the head and neck.
  • Body mass index (BMI) greater than 70 kg/m2, or unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment at any BMI value.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HFNC and NIPPVBody position changeCombined use of prone positioning and non-invasive positive pressure ventilation (NIPPV) and high-flow nasal cannula (HFNC)
Primary Outcome Measures
NameTimeMethod
Rate of intubation1 year

Number of critically ill patients with acute hypoxemic and/or hypercapnic respiratory failure, secondary to COVID-19 infection to require intubation and mechanical ventilation

Secondary Outcome Measures
NameTimeMethod
Incidence of hypotension and cardiac arrhythmias and other nursing-related risks of combining prone positioning with high-flow nasal cannula and non-invasive positive pressure ventilation1 year

To evaluate the the incidence of hypotension and cardiac arrhythmias and other nursing-related risks of combining prone positioning with high-flow nasal cannula and non-invasive positive pressure ventilation.

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath